ID

32675

Descrição

Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

Palavras-chave

  1. 12/11/2018 12/11/2018 -
Titular dos direitos

GSK group of companies

Transferido a

12 de novembro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904

Serious Adverse Event Form

Administrative data
Descrição

Administrative data

Subject Identifier
Descrição

Subject Identifier

Tipo de dados

integer

Centre Number
Descrição

Centre Number

Tipo de dados

integer

Randomisation Number
Descrição

Randomisation Number

Tipo de dados

integer

Serious Adverse Event (SAE)
Descrição

Serious Adverse Event (SAE)

Did the subject experience a serious adverse event during the study?
Descrição

Did the subject experience a serious adverse event during the study?

Tipo de dados

boolean

If YES, record details below
Descrição

If YES, record details below

Tipo de dados

text

Section 1
Descrição

Section 1

Event
Descrição

Diagnosis only (if known) Otherwise Sign/Symptom e.g., Anaphylaxis

Tipo de dados

text

Start Date
Descrição

Start Date

Tipo de dados

date

Start Time
Descrição

Start Time

Tipo de dados

time

Outcome
Descrição

Outcome

Tipo de dados

text

End Date
Descrição

If FATAL, record date of death

Tipo de dados

date

End Time
Descrição

End Time

Tipo de dados

time

Maximum Intensity
Descrição

Maximum Intensity

Tipo de dados

text

Action Taken with Investigational Product(s) as a Result of the SAE
Descrição

Action Taken with Investigational Product(s) as a Result of the SAE

Tipo de dados

text

Did the subject withdraw from study as a result of this SAE?
Descrição

Complete Study Conclusion page anf check Adverse Event as a reason for withdrawal.

Tipo de dados

boolean

Is there a reasonable possibility the SAE may have been caused by the investigational product?
Descrição

Is there a reasonable possibility the SAE may have been caused by the investigational product?

Tipo de dados

boolean

Section 2 - Seriousness
Descrição

Section 2 - Seriousness

Specify reasons for considering this a SAE
Descrição

check YES for all that apply

Tipo de dados

text

Results in death
Descrição

Results in death

Tipo de dados

boolean

Is life-threatening
Descrição

Is life-threatening

Tipo de dados

boolean

Requires hospitalisation or prolongation of existing hospitalisation
Descrição

Requires hospitalisation or prolongation of existing hospitalisation

Tipo de dados

boolean

Results in disability/incapacity
Descrição

Results in disability/incapacity

Tipo de dados

boolean

Congenital anomaly/birth defect
Descrição

Congenital anomaly/birth defect

Tipo de dados

boolean

Other, specify
Descrição

Other, specify

Tipo de dados

text

Section 3 - Demography Data
Descrição

Section 3 - Demography Data

Date of Birth
Descrição

Date of Birth

Tipo de dados

date

Sex
Descrição

Sex

Tipo de dados

text

Weight
Descrição

Weight

Tipo de dados

float

Unidades de medida
  • kg
kg
Section 4
Descrição

Section 4

If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?
Descrição

If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?

Tipo de dados

text

Section 5 - Possible Causes of SAE
Descrição

Section 5 - Possible Causes of SAE

Possible Causes other than Investgational Product
Descrição

check all that apply

Tipo de dados

integer

If MEDICAL CONDITIONS, specify
Descrição

If MEDICAL CONDITIONS, specify

Tipo de dados

text

If OTHER, specify
Descrição

If OTHER, specify

Tipo de dados

text

Section 6 - Relevant Medical Conditions
Descrição

Section 6 - Relevant Medical Conditions

Relevant past or current medical conditions
Descrição

specify all relevant past or current medical disorders, allergies, surgeries, etc. that can help explain the SAE

Tipo de dados

text

Date of Onset
Descrição

Date of Onset

Tipo de dados

date

Condition present at Time of the SAE
Descrição

Condition present at Time of the SAE

Tipo de dados

boolean

If NO, Date of Last Occurrence
Descrição

If NO, Date of Last Occurrence

Tipo de dados

date

Section 7 - Relevant Risk Factors
Descrição

Section 7 - Relevant Risk Factors

Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
Descrição

Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)

Tipo de dados

text

Section 8 - Relevant Concomitant Medications
Descrição

Section 8 - Relevant Concomitant Medications

Drug Name
Descrição

Trade name preferred e.g., Zantac

Tipo de dados

text

Dose
Descrição

Dose

Tipo de dados

float

Unit
Descrição

Unit

Tipo de dados

text

Frequency
Descrição

Frequency

Tipo de dados

text

Route
Descrição

Route

Tipo de dados

text

Taken Prior to Study
Descrição

Taken Prior to Study

Tipo de dados

boolean

Start Date
Descrição

Start Date

Tipo de dados

date

Stop Date
Descrição

Stop Date

Tipo de dados

date

Ongoing Medication
Descrição

Ongoing Medication

Tipo de dados

boolean

Reason for Medication
Descrição

e.g., Gastric ulcer

Tipo de dados

text

Section 9 - Investigational Product
Descrição

Section 9 - Investigational Product

Record details of investigational product
Descrição

Record details of investigational product

Tipo de dados

text

Section 10 - Relevant Assessment
Descrição

Section 10 - Relevant Assessment

Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE
Descrição

e.g., laboratory data with units and normal range

Tipo de dados

text

Section 11 - Narrative Remarks
Descrição

Section 11 - Narrative Remarks

Provide a brief narrative description of the SAE and details of treatment given
Descrição

Provide a brief narrative description of the SAE and details of treatment given

Tipo de dados

text

Administrative data
Descrição

Administrative data

Investigator's signature
Descrição

confirming that the data on the SAE pages are accurate and complete

Tipo de dados

text

Investigator's name (print)
Descrição

Investigator's name (print)

Tipo de dados

text

Date
Descrição

Date

Tipo de dados

date

Similar models

Serious Adverse Event Form

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Administrative data
Subject Identifier
Item
Subject Identifier
integer
Centre Number
Item
Centre Number
integer
Randomisation Number
Item
Randomisation Number
integer
Item Group
Serious Adverse Event (SAE)
Did the subject experience a serious adverse event during the study?
Item
boolean
If YES, record details below
Item
If YES, record details below
text
Item Group
Section 1
Event
Item
Event
text
Start Date
Item
Start Date
date
Start Time
Item
Start Time
time
Item
Outcome
text
Code List
Outcome
CL Item
Recovered/Resolved (1)
CL Item
Recovering/Resolving (2)
CL Item
Not recovered/Not resolved (3)
CL Item
Recovered/Resolved with sequelae (4)
CL Item
Fatal (5)
End Date
Item
End Date
date
End Time
Item
End Time
time
Item
Maximum Intensity
text
Code List
Maximum Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Not applicable (4)
Item
Action Taken with Investigational Product(s) as a Result of the SAE
text
Code List
Action Taken with Investigational Product(s) as a Result of the SAE
CL Item
Investigational product(s) withdrawn (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (6)
Did the subject withdraw from study as a result of this SAE?
Item
Did the subject withdraw from study as a result of this SAE?
boolean
Is there a reasonable possibility the SAE may have been caused by the investigational product?
Item
Is there a reasonable possibility the SAE may have been caused by the investigational product?
boolean
Item Group
Section 2 - Seriousness
Specify reasons for considering this a SAE
Item
Specify reasons for considering this a SAE
text
Results in death
Item
Results in death
boolean
Is life-threatening
Item
Is life-threatening
boolean
Requires hospitalisation or prolongation of existing hospitalisation
Item
Requires hospitalisation or prolongation of existing hospitalisation
boolean
Results in disability/incapacity
Item
Results in disability/incapacity
boolean
Congenital anomaly/birth defect
Item
Congenital anomaly/birth defect
boolean
Other, specify
Item
Other, specify
text
Item Group
Section 3 - Demography Data
Date of Birth
Item
Date of Birth
date
Item
Sex
text
Code List
Sex
CL Item
Male (1)
CL Item
Female (2)
Weight
Item
Weight
float
Item Group
Section 4
Item
If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?
text
Code List
If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)
Item Group
Section 5 - Possible Causes of SAE
Item
Possible Causes other than Investgational Product
integer
Code List
Possible Causes other than Investgational Product
CL Item
Disease under study (1)
CL Item
Medical condition(s) (2)
CL Item
Lack of efficacy (3)
CL Item
Withdrawal of investigational product(s) (4)
CL Item
Concomitant medication(s) (record details in Section 8 below) (5)
CL Item
Activity related to study participation (e.g., procedures) (6)
CL Item
Other (7)
If MEDICAL CONDITIONS, specify
Item
If MEDICAL CONDITIONS, specify
text
If OTHER, specify
Item
If OTHER, specify
text
Item Group
Section 6 - Relevant Medical Conditions
Relevant past or current medical conditions
Item
Relevant past or current medical conditions
text
Date of Onset
Item
Date of Onset
date
Condition present at Time of the SAE
Item
Condition present at Time of the SAE
boolean
If NO, Date of Last Occurrence
Item
If NO, Date of Last Occurrence
date
Item Group
Section 7 - Relevant Risk Factors
Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
Item
Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
text
Item Group
Section 8 - Relevant Concomitant Medications
Drug Name
Item
Drug Name
text
Dose
Item
Dose
float
Unit
Item
Unit
text
Frequency
Item
Frequency
text
Route
Item
Route
text
Taken Prior to Study
Item
Taken Prior to Study
boolean
Start Date
Item
Start Date
date
Stop Date
Item
Stop Date
date
Ongoing Medication
Item
Ongoing Medication
boolean
Reason for Medication
Item
Reason for Medication
text
Item Group
Section 9 - Investigational Product
Record details of investigational product
Item
Record details of investigational product
text
Item Group
Section 10 - Relevant Assessment
Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE
Item
Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE
text
Item Group
Section 11 - Narrative Remarks
Provide a brief narrative description of the SAE and details of treatment given
Item
Provide a brief narrative description of the SAE and details of treatment given
text
Item Group
Administrative data
Investigator's signature
Item
Investigator's signature
text
Investigator's name (print)
Item
Investigator's name (print)
text
Date
Item
Date
date

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial